Abstract | OBJECTIVE: METHODS: The papillary muscle specimens of the left ventricle were obtained from 18 patients with heart failure during rheumatic heart valve replacement, and the normal specimens were obtained from the autopsy of 10 adults without heart disease. The specimens were stained to examine the expression of MMP-1, MMP-9, TIMP-4, and EMMPRIN by the EnVision immunohistochemical assays. RESULTS: The expressions of MMP-1, MMP-9, and EMMPRIN in the myocardium of the patients with the cardiac function classes III and IV (NYHA III and IV) were significantly higher than those the normal cardiac function (NYHA I) (P<0.05) except MMP-1 expression between NYHA III and I. The TIMP-4 level was significantly lower in patients with NYHA III and IV than that of the NYHA I ( P<0.05). The expression of MMP-1, MMP-9, and EMMPRIN was significantly higher in patients with atrial fibrillation than those in the control group with regular sinus rhythm (P<0.05), whereas the TIMP-4 level was obviously lower in patients with atrial fibrillation than that in the control group with regular sinus rhythm (P<0.05). The expressions of MMP-1, MMP-9, and EMMPRIN were positively correlated with each other, but were negatively correlated with TIMP-4. CONCLUSION:
|
Authors | Yuan Zhao, Xinmin Zhou, Xiaobo Liao, Zhulin Yang |
Journal | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
(Zhong Nan Da Xue Xue Bao Yi Xue Ban)
Vol. 34
Issue 8
Pg. 790-5
(Aug 2009)
ISSN: 1672-7347 [Print] China |
PMID | 19734590
(Publication Type: Journal Article)
|
Chemical References |
- BSG protein, human
- Tissue Inhibitor of Metalloproteinases
- tissue inhibitor of metalloproteinase-4
- Basigin
- Matrix Metalloproteinase 9
- MMP1 protein, human
- Matrix Metalloproteinase 1
|
Topics |
- Adult
- Aged
- Basigin
(metabolism)
- Case-Control Studies
- Female
- Heart Failure
(etiology, metabolism)
- Humans
- Male
- Matrix Metalloproteinase 1
(metabolism)
- Matrix Metalloproteinase 9
(metabolism)
- Middle Aged
- Rheumatic Heart Disease
(complications, metabolism)
- Tissue Inhibitor of Metalloproteinases
(metabolism)
|